This site uses cookies, including third-party cookies, that help us to provide and improve our services.

Privacy Policy
- Global Locations -
Headquarters
Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, United States
T: +1-845-579-5705
MEA
Market Access DMCC
1602-6 Jumeirah Bay X2 Tower, Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
Americas
Future Market Insights
616 Corporate Way, Suite 2-9018,
Valley Cottage, NY 10989,
United States
T: +1-347-918-3531
Europe
Future Market Insights
3rd Floor, 207 Regent Street,
London W1B 3HH
United Kingdom
T: + 44 (0) 20 8123 9659
D: +44 (0) 20 3287 4268
APAC
Future Market Insights
Office No. 401-A, 4th Floor,
VANTAGE 9, S.No. 36/1/1,
Baner, Pune 411045 India

Fecal Pancreatic Elastase Testing Market

Market Insights on Fecal Pancreatic Elastase Testing covering sales outlook, demand forecast & up-to-date key trends

Fecal Pancreatic Elastase Testing Market By Product Type (Fecal Pancreatic Elastase ELISA Kits, Rapid Fecal Pancreatic Elastase Kits), Indication (Chronic Pancreatitis, Type 1 Diabetes, Cystic Fibrosis), End User (Hospitals, Diagnostics Laboratories, Specialty Clinics) & Region - Forecast 2022 - 2032

Fecal Pancreatic Elastase Testing Market Outlook (2022-2032)

[286 Pages Report] Global demand for fecal pancreatic elastase testing is set to experience growth at 7.7% CAGR from 2022 to 2032, exceeding US$ 14.4 Mn as of 2022. According to the latest study, fecal pancreatic elastase ELISA kits held a substantial share of over 99.0% in 2021 in the global market.

Data Points

Market Insights

Fecal Pancreatic Elastase Testing Market Value 2021

US$ 13.6 Mn

Fecal Pancreatic Elastase Testing Market Value 2022

US$ 14.4 Mn

Fecal Pancreatic Elastase Testing Market Value 2032

US$ 30.2 Mn

Fecal Pancreatic Elastase Testing Market Growth Rate (2022-2032)

7.7% CAGR

Market Share of Top 5 Countries

63.7%

Fecal pancreatic elastase testing is a kind of test that measures the amount of elastase in the stool. The demand for fecal pancreatic elastase testing is increasing globally due to rising prevalence of exocrine pancreatic insufficiency (EPI).

Elastase measurement is important because it plays a key part in digestive process by breaking down fats, proteins, and carbohydrates after eating. This test helps in determining whether the pancreas is functioning properly by keeping a check on level of pancreatic elastase.

The industry of fecal pancreatic elastase testing is also experiencing growth due to the recent product launches. Key players in the industry are introducing new products after getting regulatory approvals from the authorities.

For instance, in July 2021, Immundiagnostik AG introduced three new products based on PETIA with CE IVD approval. PETIAs tests are based on a latex agglutination reaction and provide accurate findings in minutes through quantitative measurement of pancreatic elastase in the faecal sample.

Through these product launches, key players are focusing on expanding their customer base and their product portfolio. Also, several market players are coming forward for the development and launching of new products for the detection of EPI. Backed by these aforementioned factors, the market is expected to witness robust growth over the assessment period.

Customize this Report

Let us know your requirement to get
100% FREE customization

Sales Analysis of Fecal Pancreatic Elastase Testing from 2017 to 2021 Vs Market Outlook for 2022 to 2032

The market value for fecal pancreatic elastase testing reached US$ 750.0 Mn in 2021, contributing over 2% of sales in global in-vitro diagnostic enzymes market, according to Future Market Insights.

Demand for fecal pancreatic elastase testing is surging owing to the rising prevalence of exocrine pancreatic insufficiency caused due to chronic pancreatitis. Besides this, inactive lifestyles and increased alcoholism leading to decreased production of elastase and pancreatic damage will drive the market.

According to various studies, prevalence of exocrine pancreatic insufficiency is increasing due to growing cases of cystic fibrosis across the globe. Approximately 85% of cystic fibrosis patients suffer from exocrine pancreatic insufficiency.

This EPI can be detected using fecal pancreatic elastase testing for early treatment. With increasing prevalence of cystic fibrosis, the demand for fecal pancreatic elastase testing is also expected to rise.

According to Cystic Fibrosis Foundation, approximately 70,000 people are affected by cystic fibrosis in the world every year. Hence, diagnosing and providing early treatment for the patients and fecal pancreatic elastase testing is important.

Chronic pancreatitis (CP) can be diagnosed by detecting altered structure or function of the diseased pancreas. Pancreatic function tests are more accurate than structural tests in detecting the presence of chronic pancreatitis, especially in early-stage illness.

Fecal Pancreatic Elastase Testing Market Download Report Brochure

There are two types of function tests including non-invasive and invasive. Invasive "tube" tests can consistently diagnose moderate, early CP. However, they are only accessible at a few referral hospitals and are often unpopular with patients.

Non-invasive diagnostics are easily available, but they have reduced performance in individuals with early, mild illnesses. Hence, advancement and development in the industry of fecal pancreatic elastase testing such as simple, non-invasive, cost-effective, and accurate pancreatic function tests will facilitate the growth in the market.

What are the Key Opportunities for Fecal Pancreatic Elastase Testing Manufacturers?

Stool testing is an important part of the exocrine pancreatic insufficiency diagnostic process. The 72-hour faecal fat test helps determine the existence of steatorrhea. Traditionally, the patient must be on a regular diet comprising 8–12 g of fat daily for five days for the collection of last 72-hour stool sample.

However, due to the necessity of taking 100 g of fat every day, this testing is time-intensive for the patient and not readily accepted. Furthermore, estimating faecal fat is an insensitive measurement of fat malabsorption that is only inappropriate when more than 90% of pancreatic function is lost.

As a result, this test is now deemed outdated and has been replaced by other accessible procedures such as breath tests and faecal elastase measures. This is expected to create growth opportunities for market players over the projection period.

What are the Factors Restraining Demand for Fecal Pancreatic Elastase Testing?

The demand for fecal pancreatic elastase testing is restrained due to limited awareness among people related to exocrine pancreatic insufficiency.

Constipation, diarrhoea, abdominal pain, bloating, fatty stools, and unexplained weight loss are all indications of EPI. Many other disorders can generate these symptoms as well. As a result, there is a possibility of misinterpreting the symptoms and misdiagnosed. Furthermore, individuals tend to dismiss these minor symptoms.

Individuals having persistent GI issues waited an average of 3.7 years to consult a healthcare provider, according to the American Gastroenterological Association. Furthermore, 60% surveyed stated that it was difficult to reveal GI issues to a doctor due to embarrassment.

Almost 47% stated they simply wanted to see whether their difficulties would go away. Furthermore, 66% of patients interviewed had never heard of exocrine pancreatic insufficiency (EPI), while another 21% had heard of EPI but were unfamiliar with it.

Hence, lack of awareness may act as a limitation to the growth of the fecal pancreatic elastase testing market.

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

Country-wise Insights

What Makes the U.S. the Largest Market for Fecal Pancreatic Elastase Testing?

“Rising Incidence of Pancreatitis to Increase the Need for Fecal Pancreatic Elastase Testing”

The U.S. led North America with a total market share of about 95.8% in 2021 and is expected to continue experiencing high growth throughout the forecast period. The U.S. is considered to be the most lucrative market for fecal pancreatic elastase testing.

Growth is attributed to rising prevalence of drinking leading to growing cases of pancreatitis and pancreatic insufficiency. According to the 2019 National Survey on Drug Use and Health (NSDUH), more than 85.0% of people of age 18 years and older consume alcohol at some point in their lifetime which leads to various health-related complications such as very painful and potentially fatal inflammation of the pancreas.

Why is Germany Considered to be a Lucrative Fecal Pancreatic Elastase Testing Market in Europe?

“Increasing Number of Product Launches to Facilitate the Growth in Fecal Pancreatic Elastase Testing Market”

Germany is set to exhibit growth at a CAGR of nearly 9.4% in the Europe fecal pancreatic elastase testing market during the forecast period. Growth in the market is projected to augment due to the presence of leading market players, continuous advancement and increased number of research and inventions related to various pancreatic health.

For instance, ScheBo Biotech AG from Germany, inventors created a test kit in 2021 consisting of a pancreatic elastase 1-specific antibody along with a device for sample collection. It can detect levels of elastase in faeces at a much higher accuracy than the present kits.

What Makes China an Emerging Market for Fecal Pancreatic Elastase Testing?

“China Fecal Pancreatic Elastase Testing Market to Lead the Growth in East Asia”

China held 89.0% share in the East Asian fecal pancreatic elastase testing market in 2021 and is projected to increase at a CAGR of 7.4% during the forecast period. This growth is associated with rising preference for pancreatic elastase testing.

Faecal fat tests have been used as a preliminary diagnostic test for the detection of exocrine pancreatic insufficiency. However, due to various disadvantages and inconvenient procedures, preference for fecal pancreatic elastase testing is surging among end-users.

Why is Demand for Fecal Pancreatic Elastase Testing Increasing in India?

“Prevalence of Chronic Pancreatitis to Push the Requirement for Fecal Pancreatic Elastase Testing”

India held 33.3% share in East Asia fecal pancreatic elastase testing market in 2021 and is projected to increase at a CAGR of 6.3% during the forecast period. This growth is underpinned due to rise in prevalence of pancreatic related complications such as chronic pancreatitis.

With increasing diseases and problems, the rate of diagnostic and testing options is growing, thus offering a lucrative opportunity in country during the forecast period from 2022 to 2032.

Category-wise Insights

Which Product for Fecal Pancreatic Elastase Testing is Preferred?

“99% of Fecal Pancreatic Elastase Testing Sales to be Contributed by Fecal Pancreatic Elastase ELISA Kits”

In terms of product type, fecal pancreatic elastase ELISA kits segment is expected to witness lucrative growth at a CAGR of 7.7% during the forecast period. As per FMI, the segment accounted for over  99.0% in 2021 as it provides a highly sensitive and specific determination of fecal pancreatic elastase.

It enables the clinician to establish a prompt and reliable diagnosis of suspected cases of pancreatic insufficiency. Attributes such as high accuracy, sensitivity and specificity are propelling the demand in fecal pancreatic elastase testing market during the forecast period.

How will Rising Incidence of Chronic Pancreatitis Affect Fecal Pancreatic Elastase Testing Market?

“Nearly 2/5th of Fecal Pancreatic Elastase Testing Sales Accounted by Chronic Pancreatitis”

Chronic pancreatitis held a revenue share of 34.7% in 2021. It is expected to hold the highest share in the market with increasing prevalence of chronic pancreatitis across the globe.

Hence, early detection and testing are important to avoid further health-related complications.  Chronic pancreatitis is the main cause of EPI in adults.  Around 8 out of 10 adults with CP develop EPI.

Which is the Leading End User for Fecal Pancreatic Elastase Testing?

“Availability of Skilled Professionals in Hospital to Boost the Fecal Pancreatic Elastase Testing Market”

Hospitals led the fecal pancreatic elastase testing market with more than 37.0% market share in 2021. This is because these test can be performed in hospitals by highly skilled medical professionals and require special instruments to run the test.

Become a MarketNgage Insider

An unified Market Research Subscription Platform, built for today’s disparate research needs.

Competitive Landscape

New product launches, improvements in technology, collaborations and distribution agreement between the market players are key strategies adopted by manufacturers to increase the consumer base.

  • In June 2020, BÜHLMANN announced the new CE marked turbidimetric immunoassay for the simplified quantification of human pancreatic elastase, the BÜHLMANN fPELA® turbo.
  • In May 2020, Vitassay launched Pancreatic Elastase–Turbidimetric Assay, a quantitative turbidimetric assay for the detection of human Pancreatic Elastase E1 in human solid stool samples.
  • In May 2019, DiaSorin announced the launch in the CE market of the Elastase-1
    quantification test to support the diagnosis of chronic exocrine pancreatitis on the automated LIAISON XL platform.

Scope Of Report

Attribute

Details

Forecast Period

2017-2021

Historical Data Available for

2022-2032

Market Analysis

US$ Th for Value

Key Regions Covered

North America, Latin America, Europe, South Asia, East Asia, Oceania and Middle East & Africa

Key Countries Covered

U.S., Germany, China, U.K., France, Italy, India, Spain, Thailand, Russia, Indonesia, BENELUX, Brazil, Canada, Malaysia, Mexico, Japan, Argentina, South Korea, Australia, GCC Countries, Turkey, South Africa, and New Zealand

Key Market Segments Covered

Product, Indication, End User and Region

Key Companies Profiled

  • Laboratory Corporation of America® Holdings
  • DiaSorin
  • ScheBo Biotech AG
  • Immundiagnostik AG
  • Invivo Healthcare
  • DRG Instruments GMBH
  • Verisana Laboratories
  • BÜHLMANN Laboratories AG
  • CerTest Biotec S.L.
  • R-Biopharm AG
  • American Laboratory Products Company, Ltd.
  • Vitassay Healthcare, S.L.U.

Pricing

Available upon Request

Key Market Segments Covered in Fecal pancreatic elastase testing Industry Research

By Product:

  • Fecal Pancreatic Elastase ELISA Kits
  • Rapid Fecal Pancreatic Elastase Kits

By Indication:

  • Chronic Pancreatitis
  • Type 1 Diabetes
  • Cystic Fibrosis
  • Others

By End-User:

  • Hospitals
  • Diagnostics Laboratories
  • Specialty Clinics

By Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • The Middle East and Africa (MEA)

Frequently Asked Questions

The global fecal pancreatic elastase testing market is worth US$ 13.6 Mn in 2021 and is set to expand by 2.1X over the next ten years.

The fecal pancreatic elastase testing market is expected to reach US$ 30.2 Mn by the end of 2032, registering 7.7% CAGR.

The U.S., Germany, China, U.K., and France are the top 5 countries that drive the demand for the fecal pancreatic elastase testing industry.

North America is one of the key markets for fecal pancreatic elastase testing, with the U.S. expected to account for over 95% in the North America market during the forecast period.

Demand for fecal pancreatic elastase testing in Europe is expected to register a growth of 8.3% CAGR over the next ten years.

The U.S., U.K. and Germany are key producers of fecal pancreatic elastase testing products.

Laboratory Corporation of America® Holdings, DiaSorin, ScheBo Biotech AG, Immundiagnostik AG, Invivo Healthcare, DRG Instruments GMBH, Verisana Laboratories, BÜHLMANN Laboratories AG, CerTest Biotec S.L., R-Biopharm AG, American Laboratory Products Company, Ltd., and Vitassay Healthcare, S.L.U. are the key exporters of fecal pancreatic elastase testing market.

Table of Content

1. Executive Summary

    1.1. Global Market Outlook

    1.2. Demand Side Trends

    1.3. Supply Side Trends

    1.4. Analysis and Recommendations

2. Market Overview

    2.1. Market Taxonomy

    2.2. Market Definitions

    2.3. Inclusions and Exclusions

3. Key Market Trends

    3.1. Key Trends Impacting the Market

    3.2. Product Innovation / Development Trends

4. Key Success Factors

    4.1. Diagnostic Algorithm for EPI

            4.1.1.Diagnostic Algorithm on EPI in Diabetes

            4.1.2.Key Disease Epidemiology

    4.2. Adoption Analysis

    4.3. Key Strategies Adopted by Manufacturers

    4.4. Porter’s Analysis

    4.5. PESTLE Analysis

    4.6. Value Chain Analysis

    4.7. Product USP Analysis

    4.8. Regulatory Scenario

5. Market Background

    5.1. Macro-Economic Factors

        5.1.1. Global GDP outlook

        5.1.2. Global Healthcare spending outlook

        5.1.3. Global Life expectancy outlook

    5.2. Forecast Factors - Relevance & Impact

        5.2.1. Top Companies Historical Growth

        5.2.2. Increasing Adoption of Advance Fecal Pancreatic Elastase Testing Kits

        5.2.3. Increase Prevalence of Key Indication

        5.2.4. Diagnosis rate (%)

        5.2.5. Average number of Tests per Patients

        5.2.6. Cost per Test (US$ Th)

        5.2.7. Technological Advancements in Kits

        5.2.8. Regulatory dynamics

    5.3. Market Dynamics

        5.3.1. Drivers

        5.3.2. Restraints

        5.3.3. Opportunity Analysis

    5.4. Global Supply Demand Analysis

6. COVID19 Crisis Analysis

    6.1. Current COVID19 Statistics and Probable Future Impact

    6.2. Current GDP Projection and Probable Impact

    6.3. Current Economic Projection as compared to 2008 Economic analysis

    6.4. COVID19 and Impact Analysis

        6.4.1. By Test Kits

        6.4.2. By Indication

        6.4.3. By End User

7. Global Fecal Pancreatic Elastase Testing Market - Pricing Analysis

    7.1. Global Average Pricing Analysis Benchmark

    7.2. Regional Pricing Analysis by Test Kits

    7.3. Pricing Assumptions

8. Global Fecal Pancreatic Elastase Testing Market Demand (in Volume in Units) Analysis 2017–2021 and Forecast, 2022–2032

    8.1. Historical Market Volume (Unit) Analysis, 2017–2021

    8.2. Current and Future Market Volume (Unit) Projections, 2022–2032

        8.2.1. Y-o-Y Growth Trend Analysis

9. Global Fecal Pancreatic Elastase Testing Market Demand (in Value or Size in US$ Th) Analysis 2017–2021 and Forecast, 2022–2032

    9.1. Historical Market Value (US$ Th) Analysis, 2017–2021

    9.2. Current and Future Market Value (US$ Th) Projections, 2022–2032

        9.2.1. Y-o-Y Growth Trend Analysis

        9.2.2. Absolute $ Opportunity Analysis

10. Global Fecal Pancreatic Elastase Testing Market Analysis 2017–2021 and Forecast 2022–2032, By Test Kits

    10.1. Introduction / Key Findings

    10.2. Historical Market Size (US$ Th) & Volume (Units) Analysis by Test Kits, 2017–2021

    10.3. Current and Future Market Size (US$ Th) & Volume (Units) Analysis and Forecast by Test Kits, 2022–2032

        10.3.1. Fecal Pancreatic Elastase ELISA Kits

        10.3.2. Rapid Fecal Pancreatic Elastase Kits

    10.4. Market Attractiveness Analysis by Test Kits

11. Global Fecal Pancreatic Elastase Testing Market Analysis 2017–2021 and Forecast 2022–2032, By Indication

    11.1. Introduction / Key Findings

    11.2. Historical Market Size (US$ Th) Analysis by Indication, 2017–2021

    11.3. Current and Future Market Size (US$ Th) Analysis and Forecast by Indication, 2022–2032

        11.3.1. Chronic Pancreatitis

        11.3.2. Type 1 Diabetes

        11.3.3. Cystic Fibrosis

        11.3.4. Others

    11.4. Market Attractiveness Analysis by Indication

12. Global Fecal Pancreatic Elastase Testing Market Analysis 2017–2021 and Forecast 2022–2032, by End User

    12.1. Introduction / Key Findings

    12.2. Historical Market Size (US$ Th) Analysis by End User, 2017–2021

    12.3. Current and Future Market Size (US$ Th) Analysis and Forecast by End User, 2022–2032

        12.3.1. Hospitals

        12.3.2. Diagnostic Laboratories

        12.3.3. Specialty Clinics

    12.4. Market Attractiveness Analysis by End User

13. Global Fecal Pancreatic Elastase Testing Market Analysis 2017–2021 and Forecast 2022–2032, by Region

    13.1. Introduction

    13.2. Historical Market Size (US$ Th) & Volume (Units) Analysis by Region, 2017–2021

    13.3. Current Market Size (US$ Th) & Volume (Units) Analysis and Forecast by Region, 2022–2032

        13.3.1. North America

        13.3.2. Latin America

        13.3.3. Europe

        13.3.4. South Asia

        13.3.5. East Asia

        13.3.6. Oceania

        13.3.7. Middle East & Africa

    13.4. Market Attractiveness Analysis by Region

14. North America Fecal Pancreatic Elastase Testing Market Analysis 2017–2021 and Forecast 2022–2032

    14.1. Introduction

    14.2. Pricing Analysis

    14.3. Historical Market Size (US$ Th) and Volume (Units) Trend Analysis by Market Taxonomy, 2017–2021

    14.4. Market Size (US$ Th) and Volume (Units) Forecast by Market Taxonomy, 2022–2032

        14.4.1. By Country

            14.4.1.1. U.S.

            14.4.1.2. Canada

        14.4.2. By Test Kits

        14.4.3. By Indication

        14.4.4. By End User

    14.5. Market Attractiveness Analysis

        14.5.1. By Country

        14.5.2. By Test Kits

        14.5.3. By Indication

        14.5.4. By End User

    14.6. Key Market Participants - Intensity Mapping

    14.7. Drivers and Restraints - Impact Analysis

15. Latin America Fecal Pancreatic Elastase Testing Market Analysis 2017–2021 and Forecast 2022–2032

    15.1. Introduction

    15.2. Pricing Analysis

    15.3. Historical Market Size (US$ Th) and Volume (Units) Trend Analysis by Market Taxonomy, 2017–2021

    15.4. Market Size (US$ Th) Analysis and Volume (Units) Forecast by Market Taxonomy, 2022–2032

        15.4.1. By Country

            15.4.1.1. Brazil

            15.4.1.2. Mexico

            15.4.1.3. Argentina.

        15.4.2. By Test Kits

        15.4.3. By Indication

        15.4.4. By End User

    15.5. Market Attractiveness Analysis

        15.5.1. By Country

        15.5.2. By Test Kits

        15.5.3. By Indication

        15.5.4. By End User

    15.6. Key Market Participants - Intensity Mapping

    15.7. Drivers and Restraints - Impact Analysis

16. Europe Fecal Pancreatic Elastase Testing Market Analysis 2017–2021 and Forecast 2022–2032

    16.1. Introduction

    16.2. Pricing Analysis

    16.3. Historical Market Size (US$ Th) and Volume (Units) Trend Analysis by Market Taxonomy, 2017–2021

    16.4. Market Size (US$ Th) Analysis and Volume (Units) Forecast by Market Taxonomy, 2022–2032

        16.4.1. By Country

            16.4.1.1. Germany

            16.4.1.2. Italy

            16.4.1.3. France

            16.4.1.4. U.K.

            16.4.1.5. Spain

            16.4.1.6. BENELUX

            16.4.1.7. Russia

            16.4.1.8. Rest of Europe

        16.4.2. By Test Kits

        16.4.3. By Indication

        16.4.4. By End User

    16.5. Market Attractiveness Analysis

        16.5.1. By Country

        16.5.2. By Test Kits

        16.5.3. By Indication

        16.5.4. By End User

    16.6. Key Market Participants - Intensity Mapping

    16.7. Drivers and Restraints - Impact Analysis

17. South Asia Fecal Pancreatic Elastase Testing Market Analysis 2017–2021 and Forecast 2022–2032

    17.1. Introduction

    17.2. Pricing Analysis

    17.3. Historical Market Size (US$ Th) and Volume (Units) Trend Analysis by Market Taxonomy, 2017–2021

    17.4. Market Size (US$ Th) and Volume (Units) Forecast by Market Taxonomy, 2022–2032

        17.4.1. By Country

            17.4.1.1. India

            17.4.1.2. Thailand

            17.4.1.3. Indonesia

            17.4.1.4. Malaysia

            17.4.1.5. Rest of SA

        17.4.2. By Test Kits

        17.4.3. By Indication

        17.4.4. By End User

    17.5. Market Attractiveness Analysis

        17.5.1. By Country

        17.5.2. By Test Kits

        17.5.3. By Indication

        17.5.4. By End User

    17.6. Key Market Participants - Intensity Mapping

    17.7. Drivers and Restraints - Impact Analysis

18. East Asia Fecal Pancreatic Elastase Testing Market Analysis 2017–2021 and Forecast 2022–2032

    18.1. Introduction

    18.2. Pricing Analysis

    18.3. Historical Market Size (US$ Th) and Volume (Units) Trend Analysis by Market Taxonomy, 2017–2021

    18.4. Market Size (US$ Th) and Volume (Units) Forecast by Market Taxonomy, 2022–2032

        18.4.1. By Country

            18.4.1.1. China

            18.4.1.2. Japan

            18.4.1.3. South Korea

        18.4.2. By Test Kits

        18.4.3. By Indication

        18.4.4. By End User

    18.5. Market Attractiveness Analysis

        18.5.1. By Country

        18.5.2. By Test Kits

        18.5.3. By Indication

        18.5.4. By End User

    18.6. Key Market Participants - Intensity Mapping

    18.7. Drivers and Restraints - Impact Analysis

19. Oceania Fecal Pancreatic Elastase Testing Market Analysis 2017–2021 and Forecast 2022–2032

    19.1. Introduction

    19.2. Pricing Analysis

    19.3. Historical Market Size (US$ Th) and Volume (Units) Trend Analysis by Market Taxonomy, 2017–2021

    19.4. Market Size (US$ Th) and Volume (Units) Forecast by Market Taxonomy, 2022–2032

        19.4.1. By Country

            19.4.1.1. Australia

            19.4.1.2. New Zealand

        19.4.2. By Test Kits

        19.4.3. By Indication

        19.4.4. By End User

    19.5. Market Attractiveness Analysis

        19.5.1. By Country

        19.5.2. By Test Kits

        19.5.3. By Indication

        19.5.4. By End User

    19.6. Key Market Participants - Intensity Mapping

    19.7. Drivers and Restraints - Impact Analysis

20. MEA Fecal Pancreatic Elastase Testing Market Analysis 2017–2021 and Forecast 2022–2032

    20.1. Introduction

    20.2. Pricing Analysis

    20.3. Historical Market Size (US$ Th) and Volume (Units) Trend Analysis by Market Taxonomy, 2017–2021

    20.4. Market Size (US$ Th) and Volume (Units) Forecast by Market Taxonomy, 2022–2032

        20.4.1. By Country

            20.4.1.1. GCC Countries

            20.4.1.2. Turkey

            20.4.1.3. South Africa

            20.4.1.4. Rest of MEA

        20.4.2. By Test Kits

        20.4.3. By Indication

        20.4.4. By End User

    20.5. Market Attractiveness Analysis

        20.5.1. By Country

        20.5.2. By Test Kits

        20.5.3. By Indication

        20.5.4. By End User

    20.6. Key Market Participants - Intensity Mapping

    20.7. Drivers and Restraints - Impact Analysis

21. Country Level Fecal Pancreatic Elastase Testing Market Analysis and Forecast 2022 & 2032

    21.1. Introduction

        21.1.1. Market Value Proportion Analysis

        21.1.2. Global VS. Country Growth Comparison

    21.2. U.S. Fecal Pancreatic Elastase Testing Market Analysis

        21.2.1. By Test Kits

        21.2.2. By Indication

        21.2.3. By End User

    21.3. Canada Fecal Pancreatic Elastase Testing Market Analysis

        21.3.1. By Test Kits

        21.3.2. By Indication

        21.3.3. By End User

    21.4. Brazil Fecal Pancreatic Elastase Testing Market Analysis

        21.4.1. By Test Kits

        21.4.2. By Indication

        21.4.3. By End User

    21.5. Mexico Fecal Pancreatic Elastase Testing Market Analysis

        21.5.1. By Test Kits

        21.5.2. By Indication

        21.5.3. By End User

    21.6. Argentina Fecal Pancreatic Elastase Testing Market Analysis

        21.6.1. By Test Kits

        21.6.2. By Indication

        21.6.3. By End User

    21.7. U.K. Fecal Pancreatic Elastase Testing Market Analysis

        21.7.1. By Test Kits

        21.7.2. By Indication

        21.7.3. By End User

    21.8. Germany Fecal Pancreatic Elastase Testing Market Analysis

        21.8.1. By Test Kits

        21.8.2. By Indication

        21.8.3. By End User

    21.9. Italy Fecal Pancreatic Elastase Testing Market Analysis

        21.9.1. By Test Kits

        21.9.2. By Indication

        21.9.3. By End User

    21.10. France Fecal Pancreatic Elastase Testing Market Analysis

        21.10.1. By Test Kits

        21.10.2. By Indication

        21.10.3. By End User

    21.11. Spain Fecal Pancreatic Elastase Testing Market Analysis

        21.11.1. By Test Kits

        21.11.2. By Indication

        21.11.3. By End User

    21.12. Russia Fecal Pancreatic Elastase Testing Market Analysis

        21.12.1. By Test Kits

        21.12.2. By Indication

        21.12.3. By End User

    21.13. BENELUX Fecal Pancreatic Elastase Testing Market Analysis

        21.13.1. By Test Kits

        21.13.2. By Indication

        21.13.3. By End User

    21.14. China Fecal Pancreatic Elastase Testing Market Analysis

        21.14.1. By Test Kits

        21.14.2. By Indication

        21.14.3. By End User

    21.15. Japan Fecal Pancreatic Elastase Testing Market Analysis

        21.15.1. By Test Kits

        21.15.2. By Indication

        21.15.3. By End User

    21.16. South Korea Fecal Pancreatic Elastase Testing Market Analysis

        21.16.1. By Test Kits

        21.16.2. By Indication

        21.16.3. By End User

    21.17. India Fecal Pancreatic Elastase Testing Market Analysis

        21.17.1. By Test Kits

        21.17.2. By Indication

        21.17.3. By End User

    21.18. Thailand Fecal Pancreatic Elastase Testing Market Analysis

        21.18.1. By Test Kits

        21.18.2. By Indication

        21.18.3. By End User

    21.19. Indonesia Fecal Pancreatic Elastase Testing Market Analysis

        21.19.1. By Test Kits

        21.19.2. By Indication

        21.19.3. By End User

    21.20. Malaysia Fecal Pancreatic Elastase Testing Market Analysis

        21.20.1. By Test Kits

        21.20.2. By Indication

        21.20.3. By End User

    21.21. Australia Fecal Pancreatic Elastase Testing Market Analysis

        21.21.1. By Test Kits

        21.21.2. By Indication

        21.21.3. By End User

    21.22. New Zealand Fecal Pancreatic Elastase Testing Market Analysis

        21.22.1. By Test Kits

        21.22.2. By Indication

        21.22.3. By End User

    21.23. GCC Countries Fecal Pancreatic Elastase Testing Market Analysis

        21.23.1. By Test Kits

        21.23.2. By Indication

        21.23.3. By End User

    21.24. Turkey Fecal Pancreatic Elastase Testing Market Analysis

        21.24.1. By Test Kits

        21.24.2. By Indication

        21.24.3. By End User

    21.25. South Africa Fecal Pancreatic Elastase Testing Market Analysis

        21.25.1. By Test Kits

        21.25.2. By Indication

        21.25.3. By End User

22. Market Structure Analysis

    22.1. Market Analysis by Tier of Companies (Fecal Pancreatic Elastase Testing)

    22.2. Market Share Analysis of Top Players

    22.3. Market Presence Analysis

23. Competition Analysis

    23.1. Competition Dashboard

    23.2. Competition Benchmarking

    23.3. Key Development Analysis

    23.4. Competition Deep Dive

        23.4.1. Laboratory Corporation of America® Holdings

            23.4.1.1. Overview

                23.4.1.1.1. Product Portfolio

                23.4.1.1.2. Company Key Financial

                23.4.1.1.3. Sales Footprint

                23.4.1.1.4. Strategy Overview

                23.4.1.1.5. SWOT Analysis

        23.4.2. DiaSorin

            23.4.2.1. Overview

                23.4.2.1.1. Product Portfolio

                23.4.2.1.2. Company Key Financial

                23.4.2.1.3. Sales Footprint

                23.4.2.1.4. Strategy Overview

                23.4.2.1.5. SWOT Analysis

        23.4.3. ScheBo Biotech AG

            23.4.3.1. Overview

                23.4.3.1.1. Product Portfolio

                23.4.3.1.2. Company Key Financial

                23.4.3.1.3. Sales Footprint

                23.4.3.1.4. Strategy Overview

                23.4.3.1.5. SWOT Analysis

        23.4.4. Immundiagnostik AG

            23.4.4.1. Overview

                23.4.4.1.1. Product Portfolio

                23.4.4.1.2. Company Key Financial

                23.4.4.1.3. Sales Footprint

                23.4.4.1.4. Strategy Overview

                23.4.4.1.5. SWOT Analysis

        23.4.5. Invivo Healthcare

            23.4.5.1. Overview

                23.4.5.1.1. Product Portfolio

                23.4.5.1.2. Company Key Financial

                23.4.5.1.3. Sales Footprint

                23.4.5.1.4. Strategy Overview

                23.4.5.1.5. SWOT Analysis

        23.4.6. DRG Instruments GMBH

            23.4.6.1. Overview

                23.4.6.1.1. Product Portfolio

                23.4.6.1.2. Company Key Financial

                23.4.6.1.3. Sales Footprint

                23.4.6.1.4. Strategy Overview

                23.4.6.1.5. SWOT Analysis

        23.4.7. Verisana Laboratories

            23.4.7.1. Overview

                23.4.7.1.1. Product Portfolio

                23.4.7.1.2. Company Key Financial

                23.4.7.1.3. Sales Footprint

                23.4.7.1.4. Strategy Overview

                23.4.7.1.5. SWOT Analysis

        23.4.8. BÜHLMANN Laboratories AG

            23.4.8.1. Overview

                23.4.8.1.1. Product Portfolio

                23.4.8.1.2. Company Key Financial

                23.4.8.1.3. Sales Footprint

                23.4.8.1.4. Strategy Overview

                23.4.8.1.5. SWOT Analysis

        23.4.9. CerTest Biotec S.L.

            23.4.9.1. Overview

                23.4.9.1.1. Product Portfolio

                23.4.9.1.2. Company Key Financial

                23.4.9.1.3. Sales Footprint

                23.4.9.1.4. Strategy Overview

                23.4.9.1.5. SWOT Analysis

        23.4.10. R-Biopharm AG

            23.4.10.1. Overview

                23.4.10.1.1. Product Portfolio

                23.4.10.1.2. Company Key Financial

                23.4.10.1.3. Sales Footprint

                23.4.10.1.4. Strategy Overview

                23.4.10.1.5. SWOT Analysis

        23.4.11. American Laboratory Products Company, Ltd.

            23.4.11.1. Overview

                23.4.11.1.1. Product Portfolio

                23.4.11.1.2. Company Key Financial

                23.4.11.1.3. Sales Footprint

                23.4.11.1.4. Strategy Overview

                23.4.11.1.5. SWOT Analysis

        23.4.12. Vitassay Healthcare, S.L.U.

            23.4.12.1. Overview

                23.4.12.1.1. Product Portfolio

                23.4.12.1.2. Company Key Financial

                23.4.12.1.3. Sales Footprint

                23.4.12.1.4. Strategy Overview

                23.4.12.1.5. SWOT Analysis

24. Assumptions and Acronyms Used

25. Research Methodology

Customize this Report

Let us know your requirement to get
100% FREE customization

List of Tables

Table 01: Global Fecal Pancreatic Elastase Testing Market Volume (in Units) Analysis 2017–2021 and Forecast, 2022–2032, By Test Kits

Table 02: Global Fecal Pancreatic Elastase Testing Market Size (US$ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Test Kits

Table 03: Global Fecal Pancreatic Elastase Testing Market Volume (in Units) Analysis 2017–2021 and Forecast, 2022–2032, By Indication

Table 04: Global Fecal Pancreatic Elastase Testing Market Volume (in Units) Analysis 2017–2021 and Forecast, 2022–2032, By End User

Table 05: Global Fecal Pancreatic Elastase Testing Market Volume (in Units) Analysis 2017–2021 and Forecast, 2022–2032, By Region

Table 06: Global Fecal Pancreatic Elastase Testing Market Size (US$ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Region

Table 07: North America Fecal Pancreatic Elastase Testing Market Size (US$ Th) Analysis 2017–2021 and Forecast 2022–2032, by Country

Table 08: North America Fecal Pancreatic Elastase Testing Market Volume (in Units) Analysis 2017–2021 and Forecast, 2022–2032, By Test Kits

Table 09: North America Fecal Pancreatic Elastase Testing Market Size (US$ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Test Kits

Table 10: North America Fecal Pancreatic Elastase Testing Market Value (US$ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Indication

Table 11: North America Fecal Pancreatic Elastase Testing Market Value (US$ Th) Analysis 2017–2021 and Forecast, 2022–2032, By End User

Table 12: Latin America Fecal Pancreatic Elastase Testing Market Size (US$ Th) Analysis 2017–2021 and Forecast 2022–2032, by Country

Table 13: Latin America Fecal Pancreatic Elastase Testing Market Volume (in Units) Analysis 2017–2021 and Forecast, 2022–2032, By Test Kits

Table 14: Latin America Fecal Pancreatic Elastase Testing Market Size (US$ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Test Kits

Table 15: Latin America Fecal Pancreatic Elastase Testing Market Value (US$ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Indication

Table 16: Latin America Fecal Pancreatic Elastase Testing Market Value (US$ Th) Analysis 2017–2021 and Forecast, 2022–2032, By End User

Table 17: Europe Fecal Pancreatic Elastase Testing Market Size (US$ Th) Analysis 2017–2021 and Forecast 2022–2032, by Country

Table 18: Europe Fecal Pancreatic Elastase Testing Market Volume (in Units) Analysis 2017–2021 and Forecast, 2022–2032, By Test Kits

Table 19: Europe Fecal Pancreatic Elastase Testing Market Size (US$ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Test Kits

Table 20: Europe Fecal Pancreatic Elastase Testing Market Value (US$ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Indication

Table 21: Europe Fecal Pancreatic Elastase Testing Market Value (US$ Th) Analysis 2017–2021 and Forecast, 2022–2032, By End User

Table 22: South Asia Fecal Pancreatic Elastase Testing Market Size (US$ Th) Analysis 2017–2021 and Forecast 2022–2032, by Country

Table 23: South Asia Fecal Pancreatic Elastase Testing Market Volume (in Units) Analysis 2017–2021 and Forecast, 2022–2032, By Test Kits

Table 24: South Asia Fecal Pancreatic Elastase Testing Market Size (US$ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Test Kits

Table 25: South Asia Fecal Pancreatic Elastase Testing Market Value (US$ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Indication

Table 26: South Asia Fecal Pancreatic Elastase Testing Market Value (US$ Th) Analysis 2017–2021 and Forecast, 2022–2032, By End User

Table 27: East Asia Fecal Pancreatic Elastase Testing Market Size (US$ Th) Analysis 2017–2021 and Forecast 2022–2032, by Country

Table 28: East Asia Fecal Pancreatic Elastase Testing Market Volume (in Units) Analysis 2017–2021 and Forecast, 2022–2032, By Test Kits

Table 29: East Asia Fecal Pancreatic Elastase Testing Market Size (US$ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Test Kits

Table 30: East Asia Fecal Pancreatic Elastase Testing Market Value (US$ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Indication

Table 31: East Asia Fecal Pancreatic Elastase Testing Market Value (US$ Th) Analysis 2017–2021 and Forecast, 2022–2032, By End User

Table 32: Oceania Fecal Pancreatic Elastase Testing Market Size (US$ Th) Analysis 2017–2021 and Forecast 2022–2032, by Country

Table 33: Oceania Fecal Pancreatic Elastase Testing Market Volume (in Units) Analysis 2017–2021 and Forecast, 2022–2032, By Test Kits

Table 34: Oceania Fecal Pancreatic Elastase Testing Market Size (US$ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Test Kits

Table 35: Oceania Fecal Pancreatic Elastase Testing Market Value (US$ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Indication

Table 36: Oceania Fecal Pancreatic Elastase Testing Market Value (US$ Th) Analysis 2017–2021 and Forecast, 2022–2032, By End User

Table 37: MEA Fecal Pancreatic Elastase Testing Market Size (US$ Th) Analysis 2017–2021 and Forecast 2022–2032, by Country

Table 38: MEA Fecal Pancreatic Elastase Testing Market Volume (in Units) Analysis 2017–2021 and Forecast, 2022–2032, By Test Kits

Table 39: MEA Fecal Pancreatic Elastase Testing Market Size (US$ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Test Kits

Table 40: MEA Fecal Pancreatic Elastase Testing Market Value (US$ Th) Analysis 2017–2021 and Forecast, 2022–2032, By Indication

Table 41: MEA Fecal Pancreatic Elastase Testing Market Value (US$ Th) Analysis 2017–2021 and Forecast, 2022–2032, By End User

Sabyasachi Ghosh
Principal Consultant
LinkedIn
Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Talk to Analyst

List of Charts

Figure 01: Global Average Pricing Analysis Benchmark US$ per unit (2021)

Figure 02: Fecal Pancreatic Elastase ELISA Kits Pricing Analysis (US$) for Per Unit, By Region, 2021

Figure 03: Rapid Fecal Pancreatic Elastase Kits Pricing Analysis (US$) for Per Unit, By Region, 2021

Figure 04: Global Fecal Pancreatic Elastase Testing Market Volume (in Units) Analysis, 2017–2021 

Figure 05: Global Fecal Pancreatic Elastase Testing Market Volume (in Units) & Y-o-Y Growth (%) Forecast, 2022–2032 

Figure 06: Global Fecal Pancreatic Elastase Testing Market Size (US$ Th)   Analysis, 2017–2021 

Figure 07: Global Fecal Pancreatic Elastase Testing Market Size (US$ Th) & Y-o-Y Growth (%) Forecast, 2021–2032 

Figure 08: Global Fecal Pancreatic Elastase Testing Market Absolute $ Opportunity Analysis, 2022–2032

Figure 09: Global Fecal Pancreatic Elastase Testing Market Analysis by Test Kits–2022 & 2032

Figure 10: Global Fecal Pancreatic Elastase Testing Market Y-o-Y Growth Projections by Test Kits, 2022 – 2032

Figure 11: Global Fecal Pancreatic Elastase Testing Market Attractiveness Analysis, By Test Kits, 2022-2032

Figure 12: Global Fecal Pancreatic Elastase Testing Market Analysis by Indication–2022 & 2032

Figure 13: Global Fecal Pancreatic Elastase Testing Market Y-o-Y Growth Projections by Indication, 2022 – 2032

Figure 14: Global Fecal Pancreatic Elastase Testing Market Attractiveness Analysis, By Indication, 2022-2032

Figure 15: Global Fecal Pancreatic Elastase Testing Market Analysis, By End User–2022 & 2032

Figure 16: Global Fecal Pancreatic Elastase Testing Market Y-o-Y Growth Projections, By End User, 2022 – 2032

Figure 17: Global Fecal Pancreatic Elastase Testing Market Attractiveness Analysis, By End User, 2022-2032

Figure 18: Global Fecal Pancreatic Elastase Testing Market Analysis by Region–2022 & 2032

Figure 19: Global Fecal Pancreatic Elastase Testing Market Y-o-Y Growth Projections by Region, 2022 – 2032

Figure 20: Global Fecal Pancreatic Elastase Testing Market Attractiveness Analysis, By Region, 2022-2032

Figure 21: North America Fecal Pancreatic Elastase Testing Market Value Share, By Country (2022 E)

Figure 22: North America Fecal Pancreatic Elastase Testing Market Value Share, by Test Kits (2022 E)

Figure 23: North America Fecal Pancreatic Elastase Testing Market Value Share, by Indication (2022 E)

Figure 24: North America Fecal Pancreatic Elastase Testing Market Value Share, by End User (2022 E)

Figure 25: North America Average Pricing Analysis Benchmark US$ per unit (2021)

Figure 26: North America Fecal Pancreatic Elastase Testing Market Size (US$ Th) Analysis, 2017–2021 

Figure 27: North America Fecal Pancreatic Elastase Testing Market Size (US$ Th)) & Y-o-Y Growth (%) Forecast, 2021–2032 

Figure 28: North America Fecal Pancreatic Elastase Testing Market Attractiveness Analysis, By Country, 2022-2032

Figure 29: North America Fecal Pancreatic Elastase Testing Market Attractiveness Analysis, By Test Kits, 2022-2032

Figure 30: North America Fecal Pancreatic Elastase Testing Market Attractiveness Analysis, By Indication, 2022-2032

Figure 31: North America Fecal Pancreatic Elastase Testing Market Attractiveness Analysis, By End User, 2022-2032

Figure 32: Latin America Fecal Pancreatic Elastase Testing Market Value Share, By Country (2022 E)

Figure 33: Latin America Fecal Pancreatic Elastase Testing Market Value Share, by Test Kits (2022 E)

Figure 34: Latin America Fecal Pancreatic Elastase Testing Market Value Share, by Indication (2022 E)

Figure 35: Latin America Fecal Pancreatic Elastase Testing Market Value Share, by End User (2022 E)

Figure 36: Latin America Average Pricing Analysis Benchmark US$ per unit (2021)

Figure 37: Latin America Fecal Pancreatic Elastase Testing Market Size (US$ Th) Analysis, 2017–2021 

Figure 38: Latin America Fecal Pancreatic Elastase Testing Market Size (US$ Th)) & Y-o-Y Growth (%) Forecast, 2021–2032 

Figure 39: Latin America Fecal Pancreatic Elastase Testing Market Attractiveness Analysis, By Country, 2022-2032

Figure 40: Latin America Fecal Pancreatic Elastase Testing Market Attractiveness Analysis, By Test Kits, 2022-2032

Figure 41: Latin America Fecal Pancreatic Elastase Testing Market Attractiveness Analysis, By Indication, 2022-2032

Figure 42: Latin America Fecal Pancreatic Elastase Testing Market Attractiveness Analysis, By End User, 2022-2032

Figure 43: Europe Fecal Pancreatic Elastase Testing Market Value Share, By Country (2022 E)

Figure 44: Europe Fecal Pancreatic Elastase Testing Market Value Share, by Test Kits (2022 E)

Figure 45: Europe Fecal Pancreatic Elastase Testing Market Value Share, by Indication (2022 E)

Figure 46: Europe Fecal Pancreatic Elastase Testing Market Value Share, by End User (2022 E)

Figure 47: Europe Average Pricing Analysis Benchmark US$ per unit (2021)

Figure 48: Europe Fecal Pancreatic Elastase Testing Market Size (US$ Th) Analysis, 2017–2021 

Figure 49: Europe Fecal Pancreatic Elastase Testing Market Size (US$ Th)) & Y-o-Y Growth (%) Forecast, 2021–2032 

Figure 50: Europe Fecal Pancreatic Elastase Testing Market Attractiveness Analysis, By Country, 2022-2032

Figure 51: Europe Fecal Pancreatic Elastase Testing Market Attractiveness Analysis, By Test Kits, 2022-2032

Figure 52: Europe Fecal Pancreatic Elastase Testing Market Attractiveness Analysis, By Indication, 2022-2032

Figure 53: Europe Fecal Pancreatic Elastase Testing Market Attractiveness Analysis, By End User, 2022-2032

Figure 54: South Asia Fecal Pancreatic Elastase Testing Market Value Share, By Country (2022 E)

Figure 55: South Asia Fecal Pancreatic Elastase Testing Market Value Share, by Test Kits (2022 E)

Figure 56: South Asia Fecal Pancreatic Elastase Testing Market Value Share, by Indication (2022 E)

Figure 57: South Asia Fecal Pancreatic Elastase Testing Market Value Share, by End User (2022 E)

Figure 58: South Asia Average Pricing Analysis Benchmark US$ per unit (2021)

Figure 59: South Asia Fecal Pancreatic Elastase Testing Market Size (US$ Th) Analysis, 2017–2021 

Figure 60: South Asia Fecal Pancreatic Elastase Testing Market Size (US$ Th)) & Y-o-Y Growth (%) Forecast, 2021–2032 

Figure 61: South Asia Fecal Pancreatic Elastase Testing Market Attractiveness Analysis, By Country, 2022-2032

Figure 62: South Asia Fecal Pancreatic Elastase Testing Market Attractiveness Analysis, By Test Kits, 2022-2032

Figure 63: South Asia Fecal Pancreatic Elastase Testing Market Attractiveness Analysis, By Indication, 2022-2032

Figure 64: South Asia Fecal Pancreatic Elastase Testing Market Attractiveness Analysis, By End User, 2022-2032

Figure 65: East Asia Fecal Pancreatic Elastase Testing Market Value Share, By Country (2022 E)

Figure 66: East Asia Fecal Pancreatic Elastase Testing Market Value Share, by Test Kits (2022 E)

Figure 67: East Asia Fecal Pancreatic Elastase Testing Market Value Share, by Indication (2022 E)

Figure 68: East Asia Fecal Pancreatic Elastase Testing Market Value Share, by End User (2022 E)

Figure 69: East Asia Average Pricing Analysis Benchmark US$ per unit (2021)

Figure 70: East Asia Fecal Pancreatic Elastase Testing Market Size (US$ Th) Analysis, 2017–2021 

Figure 71: East Asia Fecal Pancreatic Elastase Testing Market Size (US$ Th)) & Y-o-Y Growth (%) Forecast, 2021–2032 

Figure 72: East Asia Fecal Pancreatic Elastase Testing Market Attractiveness Analysis, By Country, 2022-2032

Figure 73: East Asia Fecal Pancreatic Elastase Testing Market Attractiveness Analysis, By Test Kits, 2022-2032

Figure 74: East Asia Fecal Pancreatic Elastase Testing Market Attractiveness Analysis, By Indication, 2022-2032

Figure 75: East Asia Fecal Pancreatic Elastase Testing Market Attractiveness Analysis, By End User, 2022-2032

Figure 76: Oceania Fecal Pancreatic Elastase Testing Market Value Share, By Country (2022 E)

Figure 77: Oceania Fecal Pancreatic Elastase Testing Market Value Share, by Test Kits (2022 E)

Figure 78: Oceania Fecal Pancreatic Elastase Testing Market Value Share, by Indication (2022 E)

Figure 79: Oceania Fecal Pancreatic Elastase Testing Market Value Share, by End User (2022 E)

Figure 80: Oceania Average Pricing Analysis Benchmark US$ per unit (2021)

Figure 81: Oceania Fecal Pancreatic Elastase Testing Market Size (US$ Th) Analysis, 2017–2021 

Figure 82: Oceania Fecal Pancreatic Elastase Testing Market Size (US$ Th)) & Y-o-Y Growth (%) Forecast, 2021–2032 

Figure 83: Oceania Fecal Pancreatic Elastase Testing Market Attractiveness Analysis, By Country, 2022-2032

Figure 84: Oceania Fecal Pancreatic Elastase Testing Market Attractiveness Analysis, By Test Kits, 2022-2032

Figure 85: Oceania Fecal Pancreatic Elastase Testing Market Attractiveness Analysis, By Indication, 2022-2032

Figure 86: Oceania Fecal Pancreatic Elastase Testing Market Attractiveness Analysis, By End User, 2022-2032

Figure 87: MEA Fecal Pancreatic Elastase Testing Market Value Share, By Country (2022 E)

Figure 88: MEA Fecal Pancreatic Elastase Testing Market Value Share, by Test Kits (2022 E)

Figure 89: MEA Fecal Pancreatic Elastase Testing Market Value Share, by Indication (2022 E)

Figure 90: MEA Fecal Pancreatic Elastase Testing Market Value Share, by End User (2022 E)

Figure 91: MEA Average Pricing Analysis Benchmark US$ per unit (2021)

Figure 92: MEA Fecal Pancreatic Elastase Testing Market Size (US$ Th) Analysis, 2017–2021 

Figure 93: MEA Fecal Pancreatic Elastase Testing Market Size (US$ Th)) & Y-o-Y Growth (%) Forecast, 2021–2032 

Figure 94: MEA Fecal Pancreatic Elastase Testing Market Attractiveness Analysis, By Country, 2022-2032

Figure 95: MEA Fecal Pancreatic Elastase Testing Market Attractiveness Analysis, By Test Kits, 2022-2032

Figure 96: MEA Fecal Pancreatic Elastase Testing Market Attractiveness Analysis, By Indication, 2022-2032

Figure 97: MEA Fecal Pancreatic Elastase Testing Market Attractiveness Analysis, By End User, 2022-2032

Figure 98: Global Fecal Pancreatic Elastase Testing Market Value Proportion Analysis, By Countries, 2022

Figure 99: Global Fecal Pancreatic Elastase Testing Market, Global Vs. Country Growth Y-o-Y (%) Comparison, 2022-2032

Figure 100: U.S. Fecal Pancreatic Elastase Testing Market Analysis by Test kits –2022 & 2032

Figure 101: U.S. Fecal Pancreatic Elastase Testing Market Analysis by Indication–2022 & 2032

Figure 102: U.S. Fecal Pancreatic Elastase Testing Market Analysis, By End User–2022 & 2032

Figure 103: Canada Fecal Pancreatic Elastase Testing Market Analysis by Test kits –2022 & 2032

Figure 104: Canada Fecal Pancreatic Elastase Testing Market Analysis by Indication–2022 & 2032

Figure 105: Canada Fecal Pancreatic Elastase Testing Market Analysis, By End User–2022 & 2032

Figure 106: Brazil Fecal Pancreatic Elastase Testing Market Analysis by Test kits –2022 & 2032

Figure 107: Brazil Fecal Pancreatic Elastase Testing Market Analysis by Indication–2022 & 2032

Figure 108: Brazil Fecal Pancreatic Elastase Testing Market Analysis, By End User–2022 & 2032

Figure 109: Mexico Fecal Pancreatic Elastase Testing Market Analysis by Test kits –2022 & 2032

Figure 110: Mexico Fecal Pancreatic Elastase Testing Market Analysis by Indication–2022 & 2032

Figure 111: Mexico Fecal Pancreatic Elastase Testing Market Analysis, By End User–2022 & 2032

Figure 112: Argentina Fecal Pancreatic Elastase Testing Market Analysis by Test kits –2022 & 2032

Figure 113: Argentina Fecal Pancreatic Elastase Testing Market Analysis by Indication–2022 & 2032

Figure 114: Argentina Fecal Pancreatic Elastase Testing Market Analysis, By End User–2022 & 2032

Figure 115: U.K. Fecal Pancreatic Elastase Testing Market Analysis by Test kits –2022 & 2032

Figure 116: U.K. Fecal Pancreatic Elastase Testing Market Analysis by Indication–2022 & 2032

Figure 117: U.K. Fecal Pancreatic Elastase Testing Market Analysis, By End User–2022 & 2032

Figure 118: Germany Fecal Pancreatic Elastase Testing Market Analysis by Test kits –2022 & 2032

Figure 119: Germany Fecal Pancreatic Elastase Testing Market Analysis by Indication–2022 & 2032

Figure 120: Germany Fecal Pancreatic Elastase Testing Market Analysis, By End User–2022 & 2032

Figure 121: Italy Fecal Pancreatic Elastase Testing Market Analysis by Test kits –2022 & 2032

Figure 122: Italy Fecal Pancreatic Elastase Testing Market Analysis by Indication–2022 & 2032

Figure 123: Italy Fecal Pancreatic Elastase Testing Market Analysis, By End User–2022 & 2032

Figure 124: France Fecal Pancreatic Elastase Testing Market Analysis by Test kits –2022 & 2032

Figure 125: France Fecal Pancreatic Elastase Testing Market Analysis by Indication–2022 & 2032

Figure 126: France Fecal Pancreatic Elastase Testing Market Analysis, By End User–2022 & 2032

Figure 127: Spain Fecal Pancreatic Elastase Testing Market Analysis by Test kits –2022 & 2032

Figure 128: Spain Fecal Pancreatic Elastase Testing Market Analysis by Indication–2022 & 2032

Figure 129: Spain Fecal Pancreatic Elastase Testing Market Analysis, By End User–2022 & 2032

Figure 130: Russia Fecal Pancreatic Elastase Testing Market Analysis by Test kits –2022 & 2032

Figure 131: Russia Fecal Pancreatic Elastase Testing Market Analysis by Indication–2022 & 2032

Figure 132: Russia Fecal Pancreatic Elastase Testing Market Analysis, By End User–2022 & 2032

Figure 133: BENELUX Fecal Pancreatic Elastase Testing Market Analysis by Test kits –2022 & 2032

Figure 134: BENELUX Fecal Pancreatic Elastase Testing Market Analysis by Indication–2022 & 2032

Figure 135: BENELUX Fecal Pancreatic Elastase Testing Market Analysis, By End User–2022 & 2032

Figure 136: China Fecal Pancreatic Elastase Testing Market Analysis by Test kits –2022 & 2032

Figure 137: China Fecal Pancreatic Elastase Testing Market Analysis by Indication–2022 & 2032

Figure 138: China Fecal Pancreatic Elastase Testing Market Analysis, By End User–2022 & 2032

Figure 139: Japan Fecal Pancreatic Elastase Testing Market Analysis by Test kits –2022 & 2032

Figure 140: Japan Fecal Pancreatic Elastase Testing Market Analysis by Indication–2022 & 2032

Figure 141: Japan Fecal Pancreatic Elastase Testing Market Analysis, By End User–2022 & 2032

Figure 142: South Korea Fecal Pancreatic Elastase Testing Market Analysis by Test kits –2022 & 2032

Figure 143: South Korea Fecal Pancreatic Elastase Testing Market Analysis by Indication–2022 & 2032

Figure 144: South Korea Fecal Pancreatic Elastase Testing Market Analysis, By End User–2022 & 2032

Figure 145: India Fecal Pancreatic Elastase Testing Market Analysis by Test kits –2022 & 2032

Figure 146: India Fecal Pancreatic Elastase Testing Market Analysis by Indication–2022 & 2032

Figure 147: India Fecal Pancreatic Elastase Testing Market Analysis, By End User–2022 & 2032

Figure 148: Thailand Fecal Pancreatic Elastase Testing Market Analysis by Test kits –2022 & 2032

Figure 149: Thailand Fecal Pancreatic Elastase Testing Market Analysis by Indication–2022 & 2032

Figure 150: Thailand Fecal Pancreatic Elastase Testing Market Analysis, By End User–2022 & 2032

Figure 151: Indonesia Fecal Pancreatic Elastase Testing Market Analysis by Test kits –2022 & 2032

Figure 152: Indonesia Fecal Pancreatic Elastase Testing Market Analysis by Indication–2022 & 2032

Figure 153: Indonesia Fecal Pancreatic Elastase Testing Market Analysis, By End User–2022 & 2032

Figure 154: Malaysia Fecal Pancreatic Elastase Testing Market Analysis by Test kits –2022 & 2032

Figure 155: Malaysia Fecal Pancreatic Elastase Testing Market Analysis by Indication–2022 & 2032

Figure 156: Malaysia Fecal Pancreatic Elastase Testing Market Analysis, By End User–2022 & 2032

Figure 157: Australia Fecal Pancreatic Elastase Testing Market Analysis by Test kits –2022 & 2032

Figure 158: Australia Fecal Pancreatic Elastase Testing Market Analysis by Indication–2022 & 2032

Figure 159: Australia Fecal Pancreatic Elastase Testing Market Analysis, By End User–2022 & 2032

Figure 160: New Zealand Fecal Pancreatic Elastase Testing Market Analysis by Test kits –2022 & 2032

Figure 161: New Zealand Fecal Pancreatic Elastase Testing Market Analysis by Indication–2022 & 2032

Figure 162: New Zealand Fecal Pancreatic Elastase Testing Market Analysis, By End User–2022 & 2032

Figure 163: GCC Countries Fecal Pancreatic Elastase Testing Market Analysis by Test kits –2022 & 2032

Figure 164: GCC Countries Fecal Pancreatic Elastase Testing Market Analysis by Indication–2022 & 2032

Figure 165: GCC Countries Fecal Pancreatic Elastase Testing Market Analysis, By End User–2022 & 2032

Figure 166: Turkey Fecal Pancreatic Elastase Testing Market Analysis by Test kits –2022 & 2032

Figure 167: Turkey Fecal Pancreatic Elastase Testing Market Analysis by Indication–2022 & 2032

Figure 168: Turkey Fecal Pancreatic Elastase Testing Market Analysis, By End User–2022 & 2032

Figure 169: South Africa Fecal Pancreatic Elastase Testing Market Analysis by Test kits –2022 & 2032

Figure 170: South Africa Fecal Pancreatic Elastase Testing Market Analysis by Indication–2022 & 2032

Figure 171: South Africa Fecal Pancreatic Elastase Testing Market Analysis, By End User–2022 & 2032

Need specific information?

Request Customization

Explore Healthcare Insights

View Reports

Recommendations

Healthcare

Fecal Pancreatic Elastase Testing Market

Published : April 2022

Healthcare

Pancreatic Elastase Testing Market

Published : October 2021

Healthcare

Pancreatic Stone Protein Testing Market

Published : October 2019

Healthcare

Pancreatic Cyst Diagnostics Market

Published : June 2019

Google translate

Fecal Pancreatic Elastase Testing Market